Sector: Health Care
Director information for ILLUMINA INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Anna Richo | Director at Exelon; Chair | 65 | ["Former General Counsel","Chief Compliance Officer","Corporate Secretary at Cargill, Inc.","B.S. in Industrial and Labor Relations from Cornell University","J.D. from DePaul University College of Law","Extensive global legal, compliance, and regulatory experience","Director at Exelon","Former General Counsel, Chief Compliance Officer and Corporate Secretary at Cargill, Inc."] | ["Nominating/Corporate Governance (Chair)"] | 2026 |
| Caroline D. Dorsa | Board Chair at Biogen; Director | 66 | ["Financial Expert","Deep knowledge of clinical markets","Audit committee financial expert under SEC rules","EVP and CFO, Public Service Enterprise Group, Inc. (2009–2015)","SVP of Global Human Health, Strategy and Integration, Merck & Co., Inc. (2008–2009)","SVP and CFO, Gilead Sciences, Inc. (2007–2008)","Various financial and operational positions at Merck & Co., Inc. (1987–2007)","Board Chair at Biogen","Director at Duke Energy"] | ["Audit","Compensation"] | 2026 |
| David P. King | Former CEO & Executive Chair of Laboratory Corporation of America; Chair, President & CEO | 69 | ["Board Chair at Privia Health","Director at Smith & Nephew","Managing Member, KingMan LLC","Extensive experience in healthcare and life sciences sectors","Operational excellence and commercial initiatives","Leading transformational change in businesses through M&A and organic initiatives","Building high-performing management teams","Former CEO & Executive Chair of Laboratory Corporation of America"] | [] | 2026 |
| Frances Arnold | Chair | [] | [] | 2026 | |
| Frances Arnold, Ph.D. | 69 | [] | [] | 2026 | |
| Gary Guthart | [] | [] | 2026 | ||
| Gary S. Guthart, Ph.D. | 60 | [] | [] | 2026 | |
| Jacob Thaysen | Chief Executive Officer | 50 | ["Chief Executive Officer, Illumina","SVP, President of Life Sciences & Applied Markets Group, Agilent Technologies","SVP, President of Diagnostics & Genomics Group, Agilent Technologies"] | [] | 2026 |
| Jacob Thaysen, Ph.D. | CEO at Illumina, Inc.; Chief Executive Officer | 50 | ["M. Sc. In Physics from the Technical University of Denmark","Ph.D. in Physics from the Technical University of Denmark","Extensive background and experience in genomics and life sciences","SVP, President of Life Sciences & Applied Markets Group at Agilent Technologies (2018 – 2023)","SVP, President of Diagnostics & Genomics Group (2014 – 2018)","VP, General Manager, Diagnostics & Genomics (2013 – 2014)","Corporate Vice President, R&D at Dako (2010 – 2013)","Chair, ALDA (Analytical, Life Science & Diagnostics Association) (since 2023)","Founder and Chief Technology Officer at Cantion","CEO at Illumina, Inc."] | [] | 2026 |
| Keith A. Meister | Founder, Managing Partner and Chief Investment Officer of Corvex Management LP; Director | 52 | ["Extensive leadership experience as managing partner and executive officer of an investment firm and a diversified holding company","Significant public company directorship experience in a variety of industries","Founder, Managing Partner and Chief Investment Officer of Corvex Management LP since 2010","Chief Executive Officer, Principal Executive Officer and Vice Chairman of the Board of Icahn Enterprises L.P. (2003 – 2010)","Senior Managing Director, Icahn Partners LP (2004 – 2010)","Public Board Service at MGM Resorts International, GeneDx Holdings Corp., Vestis Corporation","Philanthropic Board Service at Harlem Children’s Zone (Chairman) and American Museum of Natural History","Founder, Managing Partner and Chief Investment Officer of Corvex Management LP"] | ["Nominating/Corporate Governance"] | 2026 |
| Kevin Pegels | Chief of Global Operations | 59 | ["Chief of Global Operations, Illumina","Head of Global Supply Chain, Illumina"] | [] | 2026 |
| Philip W. Schiller | Apple Fellow at Apple, Inc.; Director | 65 | ["B.S. in Biology from Boston College","Apple Fellow at Apple, reporting to CEO Tim Cook","Leading the App Store and Apple Events since 2021","Senior Vice President of Worldwide Marketing at Apple (2002 – 2021)","Vice President of Product Marketing at Macromedia, Inc. (1995 – 1997)","Director of Product Marketing at FirePower Systems, Inc. (1993 – 1995)","Board of Trustees, Bowdoin College since 2019","Board of Trustees, Boston College since 2010","Listed in Forbes 'The World’s Most Influential Chief Marketing Officers' every year between 2012 and 2020","Apple Fellow at Apple, Inc."] | ["Nominating/Corporate Governance","Science and Technology"] | 2026 |
| Robert Epstein | [] | [] | 2026 | ||
| Robert S. Epstein, M.D. | 70 | [] | [] | 2026 | |
| Scott B. Ullem | CFO at Edwards Lifesciences; Director; Chair | 59 | ["Financial Expert","Chief Financial Officer, Edwards Lifesciences","CFO Bemis Company, Inc.","Managing Director at Bank of America","Managing Director at Goldman Sachs","Henry Crown Fellow at the Aspen Institute","CFO at Edwards Lifesciences"] | ["Audit"] | 2026 |
| Scott Gottlieb | [] | [] | 2026 | ||
| Scott Gottlieb, M.D. | Independent Chair | 53 | ["Partner at New Enterprise Associates","senior fellow at AEI","Former FDA Commissioner","Director at Pfizer","United Health","Tempus AI","Extensive policy expertise","Experience as FDA Commissioner (2017-2019)","Senior fellow at AEI","Various roles in public and private sectors","Venture Partner at New Enterprise Associates (2007 – 2017)","FDA Deputy Commissioner for Medical and Scientific Affairs (2005 – 2007)","Senior Advisor for Medical Technology to the FDA Commissioner (2003 – 2004)","Columnist for Wall Street Journal","Contributor to CNBC and CBS Face the Nation","Elected Member of the National Academy of Medicine","Director at United Health","Director at Tempus AI"] | ["Nominating/Corporate Governance"] | 2026 |
| Susan E. Siegel | Board Chair at MIT The Engine; Director | 65 | ["Board Director at Align Technology","Board Director at the Kaiser Family Foundation","Senior Lecturer at MIT Sloan School of Management","Extensive experience leading and growing life science companies","Driving innovation","Knowledge of genomics markets and technology","Senior Lecturer, MIT Sloan School of Management","Chief Innovation Officer of General Electric (GE)","CEO of GE Business Innovations","General Partner, Mohr Davidow Ventures","President and Board Member of Affymetrix, Inc.","Sr. Executive, Amersham Pharmacia Biotech","Board Chair at MIT The Engine"] | ["Compensation (Chair)"] | 2026 |
